I am a healthcare professional

Notice


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.


Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.


By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


Cookies


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.


You can find out more about cookies by browsing our Privacy Policy.

 

For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

EPNS 2025

-
Coming soon
06:00 AM
Duration 60mins Munich, Germany
Impact of satralizumab▼ on bone strength and muscle function in Duchenne muscular dystrophy (DMD): design of the SHIELD-DMD study
Mercuri E, De Ford C, Guridi M, Estevez-Fraga C, Peck R, Lennon-Chrimes S, Blondeau K, Craggs C, Machado V, Veerapandiyan A, Kostera-Pruszczyk A, Nascimento A, Ward LM, Proud CM

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 60mins Munich, Germany
SUNFISH PARTS 1 AND 2: 5-YEAR EFFICACY AND SAFETY DATA OF RISDIPLAM▼ IN TYPES 2 AND 3 SPINAL MUSCULAR ATROPHY
A Nascimento, J W Day, N Deconinck, E S Mazzone, M Oskoui, K Saito, C Vuillerot, G Baranello, O Boespflug-Tanguy, N Goemans, J Kirschner, A Kostera-Pruszczyk, LServais, K Sully, M Kuthiala, K Gorni, C Martin, W Y Yeung, Renata S Scalco, E Mercuri

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 60mins Munich, Germany
Retrospective assessment of feeding and nutrition after 2 years of risdiplam▼ treatment in younger children with SMA using the CEDAS
G Baranello, E Conway, Y Li, K Gorni

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 60mins Munich, Germany
Clinical Outcomes Among Risdiplam▼-Treated Patients With Spinal Muscular Atrophy (SMA) in the Cure SMA Clinical Data Registry
S Shapouri, T M To, S Whitmire, L Belter, M Schroth, R Schuldt, T Dickendesher

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 60mins Munich, Germany
International evidence-based consensus on the management of gastrointestinal adverse events related to the use of risdiplam▼ in patients with spinal muscular atrophy: methodology
C Hewamadduma and MK Korb on behalf of the SMA Delphi Panel
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 60mins Munich, Germany
3-Year Functional Outcomes of Patients With Duchenne Muscular Dystrophy: Pooled Delandistrogene Moxeparvovec Clinical Trial Data vs External Controls
Alexander P. Murphy; Jerry R. Mendell; Anne M. Connolly; John Day; Craig M. McDonald; Crystal M. Proud; Perry Shieh; Craig Zaidman; Matthew Furgerson; Kai Ding; Carol Reid; Jacob Elkins; Louise Rodino-Klapac

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
01:35 PM
Duration 7mins ICM – International Congress Center Munich
Long-Term Functional Outcomes, Safety, and Micro-Dystrophin Expression Following Delandistrogene Moxeparvovec Treatment in DMD: EMBARK 2-Year Results
Francesco Muntoni, Jerry R. Mendell, Craig M. McDonald, Eugenio M. Mercuri, Emma Ciafaloni, Hirofumi Komaki, Carmen Leon-Astudillo, Andrés Nascimento, Crystal Proud, Ulrike Schara-Schmidt, Aravindhan Veerapandiyan, Craig M. Zaidman, Matthew Furgerson, Kai Ding, Preeti Singh, Rachael Potter, Damon R. Asher, Alexander P. Murphy, Carol Reid, Gregory Hooper, Carmen O. Torre, Marianna Manfrini, Jacob S. Elkins, Louise R. Rodino-Klapac

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar